Data from a disease model showed that HSV1 infection caused tau hyperphosphorylation, forming aggregates that trapped viral ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

"Instead of just saying young women suffer from IBS, we wanted rigorous science explaining why," said co-senior author Holly Ingraham, PhD.

Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.